PT  - JOURNAL ARTICLE
AU  - Alan K Burnett
TI  - Treatment of acute myeloid leukaemia
AID  - 10.7861/clinmedicine.13-6-s58
DP  - 2013 Dec 01
TA  - Clinical Medicine
PG  - s58--s61
VI  - 13
IP  - Suppl 6
4099  - http://www.rcpjournals.org/content/13/Suppl_6/s58.short
4100  - http://www.rcpjournals.org/content/13/Suppl_6/s58.full
SO  - Clin Med2013 Dec 01; 13
AB  - Acute myeloid leukaemia is a heterogeneous disease that occurs in all age groups but peaks in older age at around a median of 69–70 years where it has a frequency of 13–15/100,00/annum. With the changing demographics, the number of cases will increase in line with the older population. As the only treatment with curative intent is intensive chemotherapy, this presents an immediate therapeutic challenge for the majority of the disease.